Volume prostata 40 cc
The current situation of cancer morbidity and mortality in the light of the National Cancer Registry, Hungary. Genes Chromosomes Cancer ; — Current state of ERG as biomarker in prostatic adenocarcinoma.
Curr Cancer Drug Targets ; — The molecular taxonomy of primary prostate cancer. Cell ; — The mutational landscape of prostate cancer.
Eur Urol. Nat Genet. SPOP mutations in prostate cancer across demographically diverse patient cohorts.
- Никто никогда не позволял себе говорить с заместителем директора АНБ в таком тоне.
- Potenciális kezelés prosztatitis
- Mi történik a prosztatában amikor gyulladás
Neoplasia ; 14— Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer. Eur J Cancer ; — Integrative clinical genomics of advanced prostate cancer.
Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer. The mutational landscape of lethal castration-resistant prostate cancer. Nature ; — Androgen receptor-mediated processes in castrate-resistant metastatic prostate cancer.
Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. Increased survival with enzalutamide in prostate cancer after chemotherapy. Abiraterone in metastatic prostate cancer without previous chemotherapy.
Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer PREVAIL : results from a randomised, phase 3 trial.
Lancet Oncol.
PTEN protein loss and clinical outcome from castration-resistant volume prostata 40 cc cancer treated with abiraterone acetate. Genetic alterations in the PI3K pathway in prostate cancer.
Anticancer Res. A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer. Clin Genitourin Cancer ; — Combination AZD with enzalutamide significantly delays enzalutamide-resistant prostate cancer in preclinical models.
Mol Cancer Ther. Abi alone in patients with metastatic castration-resistant prostate cancer mCRPC after docetaxel chemotherapy A. J Clin Oncol.
- A vetőmag buborékok és prosztata gyulladása
- Must understand and voluntarily sign a written informed consent prior to any study-related procedures being performed.
- Szöllősi János - Google Scholar
- HUA2 - Módszer prosztatatúltengés és prosztatarák kezelésére - Google Patents
- Ilona Pálné Kovács - Google Scholar
- Komplex a prosztatitis kezelésére
- A prosztatitis vizeletben
Translational and clinical implications of the genetic landscape of prostate cancer. Nat Rev Clin Oncol.
HU0000261A2 - Módszer prosztatatúltengés és prosztatarák kezelésére - Google Patents
Novel actions of next-generation taxanes benefit advanced stages of prostate cancer. Clin Cancer Res. Spatial genomic heterogeneity within localized, multifocal prostate cancer.
The importance of DNA methylation in prostate cancer development. J Steroid Biochem Mol Biol.
